Can Vistaril Increase Pulse?
Yes, hydroxyzine (Vistaril) can increase heart rate and cause tachycardia, though paradoxically it is also used therapeutically to reduce tachycardia in certain conditions like mast cell activation syndrome.
The Dual Nature of Hydroxyzine and Heart Rate
The relationship between hydroxyzine and heart rate is complex and context-dependent:
Therapeutic Use for Tachycardia Reduction
H1 antihistamines including hydroxyzine are specifically used to reduce histamine-mediated tachycardia in conditions like mast cell activation syndrome (MCAS) and mastocytosis 1, 2. In these settings, hydroxyzine blocks histamine receptors that would otherwise trigger tachycardia, making it a treatment rather than a cause of elevated heart rate.
Documented Cases of Hydroxyzine-Induced Tachycardia
However, hydroxyzine can paradoxically cause tachycardia through different mechanisms:
A documented case of supraventricular tachycardia (SVT) occurred in a 9-year-old girl on clinical doses of hydroxyzine, with a heart rate of 250/minute requiring intravenous verapamil for conversion 3. She had three prior palpitation episodes during five months of hydroxyzine use, all resolving after drug discontinuation.
Hydroxyzine toxicity in a 13-month-old manifested primarily as sinus tachycardia and seizures 4, demonstrating that excessive doses clearly increase heart rate.
In surgical settings, hydroxyzine premedication was associated with sympathetic activation and increased heart rate variability compared to midazolam 5.
Critical Cardiac Safety Concerns
QT Prolongation and Arrhythmia Risk
The FDA drug label explicitly warns that hydroxyzine can cause QT prolongation and Torsade de Pointes (TdP) 6. This is the most serious cardiac concern:
- Cases of QT prolongation and TdP have been reported in post-marketing surveillance
- The majority occurred in patients with pre-existing risk factors (heart disease, electrolyte imbalances, concomitant arrhythmogenic drugs)
- A case report documented hydroxyzine 50 mg triggering TdP in a patient with an ICD, requiring MgSO4, amiodarone, lidocaine, and ultimately sedation/intubation for resolution 7
Anticholinergic Effects
Hydroxyzine has anticholinergic properties that can contribute to tachycardia through muscarinic receptor blockade, similar to atropine-like effects.
Clinical Recommendations
Use hydroxyzine with extreme caution in patients with:
- Congenital long QT syndrome or family history of long QT
- Recent myocardial infarction
- Uncompensated heart failure
- Bradyarrhythmias
- Electrolyte imbalances (hypokalemia, hypomagnesemia)
- Concurrent use of other QT-prolonging medications 6
Monitor for:
- Baseline and periodic ECGs in at-risk patients
- Heart rate changes, especially in elderly patients who are more susceptible to anticholinergic effects
- Electrolyte levels before and during treatment
Avoid in patients with:
- Clinically significant cardiac disease
- Known QT interval prolongation
- Concurrent use of Class IA or III antiarrhythmics, certain antipsychotics, antidepressants, or antibiotics that prolong QT 6
Important Caveats
The 2019 AAAAI guidelines note concern about first-generation antihistamines like hydroxyzine in patients with MCAS who are prone to cardiovascular events 1, despite their therapeutic use for histamine-mediated tachycardia. This reflects the dual-edged nature of the drug.
In elderly patients, start with low doses and observe closely 6, as they are more susceptible to both sedation and cardiovascular effects.
The context matters significantly: hydroxyzine may reduce tachycardia when it's histamine-mediated, but can cause or worsen tachycardia through anticholinergic effects, QT prolongation, or in overdose situations.